uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Endostatin, Cathepsin S, and Cathepsin L, and Their Association with Inflammatory Markers and Mortality in Patients Undergoing Hemodialysis
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för medicinska vetenskaper, Kardiovaskulär epidemiologi.
Vise andre og tillknytning
2015 (engelsk)Inngår i: Blood Purification, ISSN 0253-5068, E-ISSN 1421-9735, Vol. 39, nr 4, s. 259-265Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

BACKGROUND/AIMS: Although both endostatin and cathepsins S have been associated with higher mortality, data in patients with end-stage renal disease (ESRD) are scarce.

METHODS: A longitudinal cohort study of 207 prevalent patients undergoing hemodialysis.

RESULTS: Cathepsins S and L were associated with soluble receptors for tumor necrosis factor (sTNFR1 and sTNFR2, rho between 0.28 and 0.43, p < 0.001 for all). Weaker or absent associations between endostatin, cathepsins S and L were seen with other inflammatory biomarkers, that is, CRP, interleukin 6, pentraxin 3, and TNF. In Cox and Laplace regression models adjusted for age, sex, dialysis vintage, and diabetes: standard deviation increments of endostatin was associated with a lower mortality (hazard ratio 0.75, 95% confidence interval (CI) 0.57-0.98), and with 6.8 months longer median survival.

CONCLUSIONS: The high levels of endostatin, cathepsins S and L, and their associations with sTNFR1 and sTNFR2 warrant further studies exploring mortality, and the angiogenic and inflammatory pathways in ESRD.

sted, utgiver, år, opplag, sider
2015. Vol. 39, nr 4, s. 259-265
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-253176DOI: 10.1159/000381664ISI: 000357832300002PubMedID: 25924922OAI: oai:DiVA.org:uu-253176DiVA, id: diva2:813592
Tilgjengelig fra: 2015-05-23 Laget: 2015-05-23 Sist oppdatert: 2017-12-04bibliografisk kontrollert

Open Access i DiVA

fulltext(413 kB)274 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 413 kBChecksum SHA-512
33fc95c844fca880d46ee33df7836133a179d41de03a056a8e9ad84d3ebe1e43cfcff61bf094402b72d874e171f25621adcb609bf8e6aec56f8db6f605007ca3
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Carlsson, Axel CLarsson, AndersÄrnlöv, Johan

Søk i DiVA

Av forfatter/redaktør
Carlsson, Axel CLarsson, AndersÄrnlöv, Johan
Av organisasjonen
I samme tidsskrift
Blood Purification

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 274 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 647 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf